Steroid 5 alpha-reductase: Comparative study of mechanism of inhibition by nonsteroids ONO-3805 and LY191704

被引:4
作者
Harris, GS [1 ]
Ellsworth, K [1 ]
Witzel, BE [1 ]
Tolman, RL [1 ]
机构
[1] MERCK SHARP & DOHME RES LABS, DEPT MED CHEM, RAHWAY, NJ 07065 USA
关键词
D O I
10.1006/bioo.1996.0033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two nonsteroids, ONO-3805 and LY191704, were evaluated as inhibitors of the human and rat 5 alpha-reductases (5 alpha R). ONO-3805 was prepared in a 12-step convergent synthesis. This compound is a potent inhibitor of the human and rat 5 alpha Rs, with more potent inhibition seen against the rat enzymes. The inhibition patterns of this compound were best fit to an uncompetitive model which suggests binding in a ternary complex with enzyme and NADP(+). Apparent K-i values of 27, 31, 1, and 0.5 nM versus testosterone were obtained with human type 1, human type 2, rat type 1, and rat type 2 5 alpha R, respectively. Multiple inhibition studies with ONO-3805 and NADP(+) support synergistic binding of these two inhibitors with all isozymes. LY191704 was also evaluated as an inhibitor of the human and rat 5 alpha Rs. This compound is a selective, competitive inhibitor of human type 1 5 alpha R. Poor inhibition was observed with human type 2 and rat types 1 and 2 5 alpha R. (C) 1996 Academic Press, Inc.
引用
收藏
页码:386 / 400
页数:15
相关论文
共 42 条
[1]   A comparison of steroidal and non-steroidal inhibitors of human steroid 5 alpha-reductase: New tricyclic aryl acid inhibitors of the type-1 isozyme [J].
Abell, AD ;
Brandt, M ;
Levy, MA ;
Holt, DA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (04) :481-484
[2]   SELECTIVE RETENTION OF DIHYDROTESTO-STERONE BY PROSTATIC NUCLEI [J].
ANDERSON, KM ;
LIAO, S .
NATURE, 1968, 219 (5151) :277-&
[3]  
ANDERSSON S, 1989, J BIOL CHEM, V264, P16249
[4]   DELETION OF STEROID 5-ALPHA-REDUCTASE 2-GENE IN MALE PSEUDOHERMAPHRODITISM [J].
ANDERSSON, S ;
BERMAN, DM ;
JENKINS, EP ;
RUSSELL, DW .
NATURE, 1991, 354 (6349) :159-161
[5]  
AUDET P, 1993, CLIN PHARMACOL THER, V53, P231
[6]   4-AZA-3-OXO-5-ALPHA-ANDROST-1-ENE-17-BETA-N-ARYL-CARBOXAMIDES AS DUAL INHIBITORS OF HUMAN TYPE-1 AND TYPE-2 STEROID 5-ALPHA-REDUCTASES - DRAMATIC EFFECT OF N-ARYL SUBSTITUENTS ON TYPE-1 AND TYPE-2 5-ALPHA-REDUCTASE INHIBITORY POTENCY [J].
BAKSHI, RK ;
RASMUSSON, GH ;
PATEL, GF ;
MOSLEY, RT ;
CHANG, B ;
ELLSWORTH, K ;
HARRIS, GS ;
TOLMAN, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3189-3192
[7]  
BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012
[8]   Mechanism-based inhibition of human steroid 5 alpha-reductase by finasteride: Enzyme-catalyzed formation of NADP-dihydrofinasteride, a potent bisubstrate analog inhibitor [J].
Bull, HG ;
GarciaCalvo, M ;
Andersson, S ;
Baginsky, WF ;
Chan, HK ;
Ellsworth, DE ;
Miller, RR ;
Stearns, RA ;
Bakshi, RK ;
Rasmusson, GH ;
Tolman, RL ;
Myers, RW ;
Kozarich, JW ;
Harris, GS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (10) :2359-2365
[9]  
CHAN HK, 1994, INT CONGR SER, V1064, P67
[10]  
ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405